Invictus MD Strategies

(OTC: IVITF)
Healthcare  |  Drug Manufacturers—Specialty & Generic
0.02 0.001 4.55%
Stock Price | July 10, 2020, 2:26 p.m.
2 Followers
Bid: 0.021
Ask: 0.05
Prev. Close: 0.022
52 Week Low: 0.0001
52 Week High: 0.05
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Read more Read less

Recently Viewed Tickers

Premium Updated Canadian LP Model Portfolio - 11/29/19

1 Comments
7 months ago

Premium Updated Canadian LP Model Portfolio - 10/31/19

8 months ago

Premium Updated Canadian LP Model Portfolio - 09/30/19

9 months ago

Premium Updated Canadian LP Model Portfolio - 08/30/19

10 months ago

Premium This Metric Suggests Valuations on Many Canadian LPs Are Reasonable

6 Comments
11 months ago

Premium Updated Canadian LP Model Portfolio - 07/31/19

11 months ago

Premium Cannabis Stocks Review - Weekend Edition 07/08/19

30 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 07/01/19

31 Comments
1 year ago

Premium Updated Canadian LP Model Portfolio - 06/28/19

1 year ago

Premium Cannabis Stocks Review - Weekend Edition 06/24/19

37 Comments
1 year ago